News

The National Institutes of Health/National Heart Lung and Blood Institute recently awarded a five-year $3.8 million grant to the University of Kentucky to begin a new study aimed at improving diet and activity among rural Appalachian Kentuckians. 

“We hope to better understand how sulfur accumulates in biofuel feedstocks, what happens to the sulfur during thermochemical conversion, how to remove sulfur and improve gasification efficiency.”

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

A new $3 million grant from the National Science Foundation (NSF) will expand FABRIC, a project to build the nation’s largest cyberinfrastructure testbed, to four distinguished scientific institutions in Asia and Europe.

This year’s Barnstable Brown Diabetes and Obesity Research Day will be a series of virtual seminars and activities during November. This also coincides with National Diabetes Month. The Series will include prominent speakers in the areas of diabetes and obesity research.

The RUHRC was established in 2016, with an initial HRSA funding award of $2.8 million. Since then, the Center has produced 22 research products, including policy briefs and peer-reviewed publications, as well as more than a dozen related publications.

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Although small tattoos are less likely to interfere with overall body temperature regulation, decreased sweating in tattooed skin “could impact heat dissipation especially when tattooing covers a higher percentage of body surface area,” the researchers wrote.

A $2.9 million grant from the NIH is supporting a multidisciplinary team of UK researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.

Dr. Emma Birks, UK HealthCare's heart failure section chief, is working on a new treatment therapy that recovers the hearts of some patients with advanced-stage chronic heart failure and ultimately cut down the number of heart transplants needed.